Skip to main content

J&J to seek FDA authorization for booster shot

By The New York Times  
   October 04, 2021

The request, expected this week, comes after a study found the company's vaccine was only 71% effective against hospitalization from COVID-19.

Full story


Get the latest on healthcare leadership in your inbox.